NASDAQ: PLRX - Pliant Therapeutics, Inc.

Rentabilidade por seis meses: -21.72%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Pliant Therapeutics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, обнаруживает, разрабатывает и коммерциализирует новые методы лечения фиброза и связанных с ним заболеваний в Соединенных Штатах. Ведущим кандидатом на продукт является PLN-74809, низкомолекулярный двойной селективный ингибитор интегринов avß6 и avß1 для перорального применения, который находится в фазе II, отслеживается однократная возрастающая доза / многократная возрастающая доза, и завершены испытания фазы Ib с доказательством наличия механизма.

mais detalhes
для лечения идиопатического фиброза легких и первичного склерозирующего холангита. Компания также разрабатывает PLN-1474, низкомолекулярный селективный ингибитор avß1, который завершил фазу 1 клинических испытаний по лечению фиброза печени, связанного с неалкогольным стеатогепатитом. Кроме того, он разрабатывает две дополнительные доклинические программы на основе интегринов, которые включают программу онкологии, а также программу для аллостерических агонистических моноклональных антител против нераскрытого рецептора интегрина для лечения мышечных дистрофий, включая мышечную дистрофию Дюшенна. Pliant Therapeutics, Inc. была основана в 2015 году и базируется в Южном Сан-Франциско, Калифорния.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2020-06-03
ISIN US7291391057
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://pliantrx.com
Цена ао 11.55
Alteração de preço por dia: -1.97% (11.14)
Alteração de preço por semana: -2.59% (11.21)
Alteração de preço por mês: -19.05% (13.49)
Alteração de preço em 3 meses: -22.83% (14.15)
Mudança de preço em seis meses: -21.72% (13.95)
Mudança de preço por ano: -36.29% (17.14)
Mudança de preço em 3 anos: +10.75% (9.86)
Mudança de preço em 5 anos: 0% (10.92)
Mudança de preço em 10 anos: 0% (10.92)
Mudança de preço desde o início do ano: -24.01% (14.37)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 688.28 1
P/BV 2.3 6
P/E 49.43 3
EV/EBITDA -5.68 0
Total: 3.63

Eficiência

Nome Significado Nota
ROA, % -31.5 0
ROE, % -34.07 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0624 10
Total: 9

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % -97.23 0
Rentabilidade Ebitda, % -32927.39 0
Rentabilidade EPS, % 357.93 10
Total: 6
Mais detalhes

Data da transação Data de divulgação Insider Tipo Preço Volume Quantidade Compartilhe até, % Compartilhe depois, % Documento
17.01.2025 22.01.2025 Cummings Keith Lamont
Chief Financial Officer		 Oferta 11.2 225 658 20148 0 -0.06 link
17.01.2025 22.01.2025 Coulie Bernard
President and CEO		 Oferta 11.2 587 093 52419 0 -0.15 link
04.08.2023 07.08.2023 Hull Hans
Chief Business Officer		 Oferta 20.01 401 201 20050 0 -0.06 link
04.08.2023 07.08.2023 Hull Hans
Chief Business Officer		 Comprar 2.08 18 285 8791 0 0.02 link
03.08.2023 07.08.2023 Hull Hans
Chief Business Officer		 Oferta 20 261 380 13069 0 -0.04 link
03.08.2023 07.08.2023 Hull Hans
Chief Business Officer		 Comprar 2.08 3 744 1800 0 0 link
17.07.2023 19.07.2023 Coulie Bernard
President and CEO		 Oferta 18.01 1 263 400 70150 0 -0.19 link
17.07.2023 19.07.2023 Cummings Keith Lamont
Chief Financial Officer		 Oferta 18.01 356 076 19771 0 -0.05 link
03.04.2023 03.04.2023 Ouimette Mike
General Counsel & Corp. Sec'y		 Oferta 26.79 77 075 2877 0 -0.01 link
30.03.2023 03.04.2023 Lefebvre Eric
Chief Medical Officer		 Oferta 26.52 298 217 11245 0 -0.03 link
30.03.2023 03.04.2023 Ouimette Mike
General Counsel & Corp. Sec'y		 Oferta 26.52 129 258 4874 0 -0.01 link
12.07.2022 13.07.2022 Coulie Bernard
President and CEO		 Oferta 22.5 281 205 12498 0 -0.03 link
12.07.2022 13.07.2022 Coulie Bernard
President and CEO		 Comprar 2.08 25 996 12498 0 0.03 link
11.07.2022 13.07.2022 Coulie Bernard
President and CEO		 Oferta 22.5 337 500 15000 0 -0.04 link
11.07.2022 13.07.2022 Coulie Bernard
President and CEO		 Comprar 2.08 31 200 15000 0 0.04 link
11.07.2022 13.07.2022 Lefebvre Eric
Chief Medical Officer		 Oferta 20 60 000 3000 0 -0.01 link

Instituições Volume Compartilhar, %
Deep Track Capital, LP 5750000 9.55
Blackrock Inc. 4801517 7.97
FMR, LLC 3963418 6.58
Price (T.Rowe) Associates Inc 3785916 6.28
First Light Asset Management, LLC 3591776 5.96
Laurion Capital Management, LP 3583567 5.95
Vanguard Group Inc 3065869 5.09
Blue Owl Capital Holdings LP 3004199 4.99
Redmile Group, LLC 2696648 4.48
TRV GP IV, LLC 2132867 3.54

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Virtus LifeSci Biotech Clinical Trials ETF 0.80292 63.04 0.33
SPDR S&P Pharmaceuticals ETF 0.79551 29.8 1.29889
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 0.45183 86.72 1.2989
iShares U.S. Pharmaceuticals ETF 0.2511 6.09 1.97922
Avantis U.S Small Cap Equity ETF 0.08004 27.77 1.68271
Invesco Nasdaq Biotechnology ETF 0.07324 28.58 0.8565
Future Tech ETF 0.07066 426.34 0.8416
Principal Healthcare Innovators ETF 0.07066 618.5 0.8416
ProShares Ultra Nasdaq Biotechnology 0.0501 51.7 0.85651
iShares ESG Aware MSCI USA Small-Cap ETF 0.04224 18.09 1.49366
Nuveen ESG Small-Cap ETF 0.04153 13.91 1.41019
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.03704 24.75 1.59225
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.02149 31.36 1.41955
Schwab U.S. Small-Cap ETF 0.01649 17.47 1.51433
iShares Morningstar Small Cap Value ETF 0.0158 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.0158 201.65 2.50476
ProShares UltraPro Russell2000 0.01495 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01142 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.01142 30.1 1.60498
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.00995 17.58 1.75869
Fidelity MSCI Health Care Index ETF 0.00887 3 1.46057
iShares Morningstar Small-Cap Growth ETF 0.00756 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.00756 587.89 0.72598
ProShares Hedge Replication ETF 0.00433 5.92 1.47892
Humankind US Stock ETF 0.00382 18.81 1.99919
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00368 21.94 1.69572
Dimensional U.S. Targeted Value ETF 0.00164 26.01 1.93487
Schwab U.S. Broad Market ETF 0.00128 24.86 1.43354
iShares Russell 3000 ETF 0.00122 24.83 1.43482
Dimensional US Core Equity Market ETF 0.00107 30.98 1.40618
Dimensional U.S. Core Equity 2 ETF 0.00089 30.76 1.47098
Dimensional U.S. Equity ETF 0.00087 31.53 1.3557
Avantis U.S. Equity ETF 0.00052 23.04 1.59151
Avantis Responsible U.S. Equity ETF 0.00016 26.78 1.45257
Vanguard Russell 3000 ETF 0 31.87 1.43817



Supervisor Cargo Pagamento Ano de nascimento
Mr. Johannes P. Hull Chief Business Officer 631.64k 1975 (50 anos)
Dr. Rik Derynck Scientific Founder & Member of Scientific Advisory Board N/A
Mr. Dean Sheppard M.D. Scientific Founder & Member of Scientific Advisory Board N/A
Mr. Bill DeGrado Ph.D. Scientific Founder & Member of Scientific Advisory Board N/A
Mr. Hal Chapman M.D. Scientific Founder & Member of Scientific Advisory Board N/A
Dr. Keith Lamont Cummings M.B.A., M.D. Chief Financial Officer 662.34k 1977 (48 anos)
Mr. Craig D. Muir Interim Chief Technology Officer N/A
Mr. Mike Ouimette J.D. General Counsel & Corporate Secretary 591.05k 1973 (52 ano)
Dr. Bernard Coulie M.B.A., M.D., Ph.D. President, CEO & Director 1.06M 1967 (58 anos)
Dr. Eric A. Lefebvre M.D. Chief Medical Officer 1964 (61 ano)

Endereço: United States, South San Francisco, CA , 260 Littlefield Avenue - abrir no Google Maps, abrir mapas Yandex
Site: http://pliantrx.com